| Time Point . | Estimated Mean (95% CI) for Following Group: . | ||
|---|---|---|---|
| . | Fluoroscopy-Guided MLD . | Traditional MLD . | Placebo MLD . |
| B0 | 33.1 (26.1–40.1) | 32.3 (25.3–39.3) | 34.9 (28–41.8) |
| P | 24.4c (19.1–29.6) | 25.4c (20.2–30.7) | 23.9d (18.7–29.1) |
| P1 | 30.0 (22.2–37.8) | 29.5 (21.6–37.3) | 25.3c (17.6–33.0) |
| P3 | 20.9d (16.6–25.2) | 22.2d (17.8–26.5) | 21.1d (16.8–25.4) |
| P6 | 22.8d (17.1–28.5) | 22.6c (16.8–28.3) | 21.6d (16.0–27.3) |
| P12 | 28.1 (20.0–36.2) | 24.1c (16.0–32.3) | 25.4c (17.3–33.4) |
| Time Point . | Estimated Mean (95% CI) for Following Group: . | ||
|---|---|---|---|
| . | Fluoroscopy-Guided MLD . | Traditional MLD . | Placebo MLD . |
| B0 | 33.1 (26.1–40.1) | 32.3 (25.3–39.3) | 34.9 (28–41.8) |
| P | 24.4c (19.1–29.6) | 25.4c (20.2–30.7) | 23.9d (18.7–29.1) |
| P1 | 30.0 (22.2–37.8) | 29.5 (21.6–37.3) | 25.3c (17.6–33.0) |
| P3 | 20.9d (16.6–25.2) | 22.2d (17.8–26.5) | 21.1d (16.8–25.4) |
| P6 | 22.8d (17.1–28.5) | 22.6c (16.8–28.3) | 21.6d (16.0–27.3) |
| P12 | 28.1 (20.0–36.2) | 24.1c (16.0–32.3) | 25.4c (17.3–33.4) |
Represented by L-Dex scores. B0 = baseline; MLD = manual lymph drainage; P = after intensive treatment; P1, P3, P6, and P12 = after 1, 3, 6, and 12 months of maintenance treatment, respectively.
Significance of relative changes vs baseline in each treatment group at different time points. The P value for the overall interaction effect (group × time) was .950. MLD = manual lymph drainage.
With regard to within-group differences, P < .05 for changes in the estimated mean vs baseline that were statistically significant.
With regard to within-group differences, P < .0001 for changes in the estimated mean vs baseline that were statistically significant.
| Time Point . | Estimated Mean (95% CI) for Following Group: . | ||
|---|---|---|---|
| . | Fluoroscopy-Guided MLD . | Traditional MLD . | Placebo MLD . |
| B0 | 33.1 (26.1–40.1) | 32.3 (25.3–39.3) | 34.9 (28–41.8) |
| P | 24.4c (19.1–29.6) | 25.4c (20.2–30.7) | 23.9d (18.7–29.1) |
| P1 | 30.0 (22.2–37.8) | 29.5 (21.6–37.3) | 25.3c (17.6–33.0) |
| P3 | 20.9d (16.6–25.2) | 22.2d (17.8–26.5) | 21.1d (16.8–25.4) |
| P6 | 22.8d (17.1–28.5) | 22.6c (16.8–28.3) | 21.6d (16.0–27.3) |
| P12 | 28.1 (20.0–36.2) | 24.1c (16.0–32.3) | 25.4c (17.3–33.4) |
| Time Point . | Estimated Mean (95% CI) for Following Group: . | ||
|---|---|---|---|
| . | Fluoroscopy-Guided MLD . | Traditional MLD . | Placebo MLD . |
| B0 | 33.1 (26.1–40.1) | 32.3 (25.3–39.3) | 34.9 (28–41.8) |
| P | 24.4c (19.1–29.6) | 25.4c (20.2–30.7) | 23.9d (18.7–29.1) |
| P1 | 30.0 (22.2–37.8) | 29.5 (21.6–37.3) | 25.3c (17.6–33.0) |
| P3 | 20.9d (16.6–25.2) | 22.2d (17.8–26.5) | 21.1d (16.8–25.4) |
| P6 | 22.8d (17.1–28.5) | 22.6c (16.8–28.3) | 21.6d (16.0–27.3) |
| P12 | 28.1 (20.0–36.2) | 24.1c (16.0–32.3) | 25.4c (17.3–33.4) |
Represented by L-Dex scores. B0 = baseline; MLD = manual lymph drainage; P = after intensive treatment; P1, P3, P6, and P12 = after 1, 3, 6, and 12 months of maintenance treatment, respectively.
Significance of relative changes vs baseline in each treatment group at different time points. The P value for the overall interaction effect (group × time) was .950. MLD = manual lymph drainage.
With regard to within-group differences, P < .05 for changes in the estimated mean vs baseline that were statistically significant.
With regard to within-group differences, P < .0001 for changes in the estimated mean vs baseline that were statistically significant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
